Safety and Efficacy of Nusinersen and Risdiplam for Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Objective: We performed a systematic review and meta-analysis of the efficacy and safety of nusinersen and risdiplam in the treatment of spinal muscular disease (SMA). Methods: We screened the literature published in Pubmed, Web of Science, Embase, and Cochrane before July 2023 to conduct randomized...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yue Qiao, Yuewei Chi, Jian Gu, Ying Ma
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-10-01
coleção:	Brain Sciences
Assuntos:	spinal muscular atrophy nusinersen risdiplam meta-analysis efficacy safety
Acesso em linha:	https://www.mdpi.com/2076-3425/13/10/1419
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!